Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 2
1997 4
1998 3
1999 3
2000 8
2001 3
2002 4
2003 3
2004 4
2005 2
2006 4
2007 6
2009 5
2010 6
2011 5
2012 7
2013 7
2014 3
2015 5
2016 6
2017 6
2019 3
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

96 results
Results by year
Filters applied: . Clear all
Page 1
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.
Bogucka K, Marini F, Rosigkeit S, Schloeder J, Jonuleit H, David K, Schlackow M, Rajalingam K. Bogucka K, et al. Among authors: jonuleit h. Cancer Gene Ther. 2020 Oct 17. doi: 10.1038/s41417-020-00245-w. Online ahead of print. Cancer Gene Ther. 2020. PMID: 33070159
Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.
Bogucka K, Marini F, Rosigkeit S, Schloeder J, Jonuleit H, David K, Schlackow M, Rajalingam K. Bogucka K, et al. Among authors: jonuleit h. Cancer Gene Ther. 2020 Nov 9. doi: 10.1038/s41417-020-00250-z. Online ahead of print. Cancer Gene Ther. 2020. PMID: 33168935 No abstract available.
Dendritic cells: sentinels of immunity and tolerance.
Kubach J, Becker C, Schmitt E, Steinbrink K, Huter E, Tuettenberg A, Jonuleit H. Kubach J, et al. Among authors: jonuleit h. Int J Hematol. 2005 Apr;81(3):197-203. doi: 10.1532/IJH97.04165. Int J Hematol. 2005. PMID: 15814330 Review.
96 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page